|
1
|
Alahdab F, Wang AT, Elraiyah TA, Malgor
RD, Rizvi AZ, Lane MA, Prokop LJ, Montori VM, Conte MS and Murad
MH: A systematic review for the screening for peripheral arterial
disease in asymptomatic patients. J Vasc Surg. 61 Suppl 3:S42–S53.
2015. View Article : Google Scholar
|
|
2
|
Criqui MH and Aboyans V: Epidemiology of
peripheral artery disease. Circ Res. 116:1509–1526. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin TY, Yang FC, Lin CL, Kao CH, Lo HY and
Yang TY: Herpes zoster infection increases the risk of peripheral
arterial disease: A nationwide cohort study. Medicine (Baltimore).
95:e44802016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baerlocher MO, Kennedy SA, Rajebi MR,
Baerlocher FJ, Misra S, Liu D and Nikolic B: Meta-analysis of
drug-eluting balloon angioplasty and drug-eluting stent placement
for infrainguinal peripheral arterial disease. J Vasc Interv
Radiol. 26:459–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumada Y, Aoyama T, Ishii H, Tanaka M,
Kawamura Y, Takahashi H, Toriyama T, Aoyama T, Yuzawa Y, Maruyama
S, et al: Long-term outcome of percutaneous transluminal
angioplasty in chronic haemodialysis patients with peripheral
arterial disease. Nephrol Dial Transplant. 23:3996–4001. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koskinas KC, Chatzizisis YS, Antoniadis AP
and Giannoglou GD: Role of endothelial shear stress in stent
restenosis and thrombosis: Pathophysiologic mechanisms and
implications for clinical translation. J Am Coll Cardiol.
59:1337–1349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilson WR, Fitridge RA, Weekes AJ, Morgan
C, Tavella R and Beltrame JF: Quality of life of patients with
peripheral arterial disease and chronic stable angina. Angiology.
63:223–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumakura H, Kanai H, Araki Y, Hojo Y,
Iwasaki T and Ichikawa S: 15-year patency and life expectancy after
primary stenting guided by intravascular ultrasound for iliac
artery lesions in peripheral arterial disease. JACC Cardiovasc
Interv. 8:1893–1901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kutlar A, Ataga KI, McMahon L, Howard J,
Galacteros F, Hagar W, Vichinsky E, Cheung AT, Matsui N and Embury
SH: A potent oral P-selectin blocking agent improves
microcirculatory blood flow and a marker of endothelial cell injury
in patients with sickle cell disease. Am J Hematol. 87:536–539.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abraham D and Distler O: How does
endothelial cell injury start? The role of endothelin in systemic
sclerosis. Arthritis Res Ther. 9 Suppl 2:S22007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michel JB, Li Z and Lacolley P: Smooth
muscle cells and vascular diseases. Cardiovasc Res. 95:135–137.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gu P, Theiss A, Han J and Feagins LA:
Increased cell adhesion molecules, PECAM-1, ICAM-3, or VCAM-1,
predict increased risk for flare in patients with quiescent
inflammatory bowel disease. J Clin Gastroenterol. 51:522–527. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thomas MR, Wijeyeratne YD, May JA, Johnson
A, Heptinstall S and Fox SC: A platelet P-selectin test predicts
adverse cardiovascular events in patients with acute coronary
syndromes treated with aspirin and clopidogrel. Platelets.
25:612–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Myers DD Jr, Henke PK, Bedard PW,
Wrobleski SK, Kaila N, Shaw G, Meier TR, Hawley AE, Schaub RG and
Wakefield TW: Treatment with an oral small molecule inhibitor of P
selectin (PSI-697) decreases vein wall injury in a rat stenosis
model of venous thrombosis. J Vasc Surg. 44:625–632. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pabinger I and Ay C: Biomarkers and venous
thromboembolism. Arterioscler Thromb Vasc Biol. 29:332–336. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Geng JG, Chen M and Chou KC: P-selectin
cell adhesion molecule in inflammation, thrombosis, cancer growth
and metastasis. Curr Med Chem. 11:2153–2160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Panicker SR, Mehta-D'souza P, Zhang N,
Klopocki AG, Shao B and Mcever RP: Circulating soluble P-selectin
must dimerize to promote inflammation and coagulation in mice.
Blood. 130:181–191. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pabinger I and Ay C: Biomarkers and venous
thromboembolism. Arterioscler Thromb Vasc Biol. 29:332–336. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Biasin V, Chwalek K, Wilhelm J, Best J,
Marsh LM, Ghanim B, Klepetko W, Fink L, Schermuly RT, Weissmann N,
et al: Endothelin-1 driven proliferation of pulmonary arterial
smooth muscle cells is c-fos dependent. Int J Biochem Cell Biol.
54:137–148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang HN, Zeng B, Chen GL, Lai B, Lu SH
and Qu JM: Lipopolysaccharide potentiates endothelin-1-induced
proliferation of pulmonary arterial smooth muscle cells by
upregulating TRPC channels. Biomed Pharmacother. 82:20–27. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meoli DF and White RJ: Endothelin-1
induces pulmonary but not aortic smooth muscle cell migration by
activating ERK1/2 MAP kinase. Can J Physiol Pharmacol. 88:830–839.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Romano F, Gambara G, De Cesaris P, Ziparo
E, Palombi F and Filippini A: Endothelin induces functional
hypertrophy of peritubular smooth muscle cells. J Cell Physiol.
212:264–273. 2007. View Article : Google Scholar : PubMed/NCBI
|
